Novavax NVAX announced encouraging results from an initial cohort of a late-stage study evaluating its experimental ...

Novavax's experimental COVID-19-influenza combination and standalone influenza vaccines generated a strong immune response in ...

Biotech investors await the fallout from US Health Secretary RFK's "extraordinary" move to sack all 17 members of a powerful vaccines panel.

A severe flu season ahead? Amid warning signs of a potentially severe flu season ahead, those experts worry "vaccine fatigue" will keep people from getting their flu shot – and with it, a simple, safe ...

Children as young as 6-months-old may still receive COVID-19 vaccines, the Centers for Disease Control and Prevention (CDC) advised Thursday — but the shot is no longer recommended for healthy kids.

The cancelation came as Moderna announced positive interim results from an early-stage trial of the vaccine that targeted H5 bird flu virus, tested in 300 healthy adults. “While the termination ...

as bird flu spread among livestock and occasional farmworkers. Will you be able to get a COVID-19 shot? Here’s what we know so far The Trump administration told the company in February it was ...

including H5N1 bird flu. In the same statement, Moderna also announced that the new vaccine it had been developing against H5 influenza strains, mRNA-1018, had positive results after being tested ...

Results from Moderna’s bird flu vaccine research were positive and generated “a rapid, potent and durable immune response,” the company said in a statement. Never miss a story — sign up ...

The Trump administration has canceled a contract with the drugmaker Moderna to develop a vaccine for humans to fight off the bird flu, according to CBS News. On Wednesday, the U.S. Health and Human ...

Moderna MRNA recently announced that the U.S. government has terminated the previously-awarded contract for the late-stage development of an mRNA-based bird flu vaccine, as well as the right to ...